Keohane et al. — Short-term high-purity spermidine trial
Minimal changes in circulating polyamines; no product-related adverse events reported.
The record
- Year
- 2024
- Design
- Exploratory randomized, double-blind, placebo-controlled study
- Population
- 37 healthy men aged 50–70; up to 28 days
Short duration, selected men and industry involvement; no lifespan outcome.